Iambic’s physics-informed NeuralPLexer is intended to enhance protein–ligand modeling, enabling broader exploration of ...
Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US ...
In this PharmTech video feature, I highlight the week’s industry news in an easy-to-consume format. New roundups drop every ...
ACG’s Shirwal site is the first pharmaceutical packaging site in the WEF Lighthouse Network, using digital tools to cut ...
Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated ...
In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...
Marcio Temtem, vice president, Strategic Business Management, Hovione, addresses molecule complexity, speed, and ...
The companies’ “Change the Target. Change What’s Possible” targets the potential of Factor XIa inhibition in the development ...
Priority Review was granted by FDA for the first line metastatic TNBC treatment. Datroway significantly improved survival ...
Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...
Nine recommendations for extending therapeutic indications reflect ongoing lifecycle management and utility expansion of ...
FDA Commissioner Marty Makary, M.D., M.P.H., characterized the program as a “bold step” to bring manufacturing back to the US and make the domestic sector more resilient and competitive. This program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results